Miromatrix Medical (MIRO) Competitor Comparison
We are evaluating the key criteria listed to compare Miromatrix Medical (MIRO) against its competitors in the Biotechnology industry.
Market Capitalization
266 / 368Gross Profits
0 / 278Total Revenue
237 / 300EBITDA
103 / 337Free Cashflow
114 / 352Quick Ratio
254 / 357Earnings per Share
143 / 359Dividend yield
0 / 6Total Cash
306 / 358Performance 3 years
209 / 368Performance 5 years
213 / 368Performance 10 years
187 / 368Linearity 3 years
214 / 368Linearity 5 years
238 / 368Linearity 10 years
211 / 368Total Rank
201 / 368Dividend Rank
207 / 368Valuation Rank
288 / 368Piotroski Rank
238 / 368Muliplier Rank
158 / 368Muliplier Rank - MIRO ranking 158 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.